Ionis Pharmaceuticals, Inc. (IONS)
74.23
-1.45
(-1.92%)
USD |
NASDAQ |
May 15, 16:00
74.24
+0.01
(+0.01%)
After-Hours: 20:00
Ionis Pharmaceuticals EPS Diluted (Quarterly) : -0.5612 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biogen, Inc. | 2.153 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| BioMarin Pharmaceutical, Inc. | 0.5431 |
| Mirum Pharmaceuticals, Inc. | -13.43 |
| Catalyst Pharmaceuticals, Inc. | 0.5022 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -92.53M |
| Revenue (Quarterly) | 246.09M |
| Total Expenses (Quarterly) | 338.62M |
| Enterprise Value | 12.90B |
| Gross Profit Margin (Quarterly) | 95.76% |
| Profit Margin (Quarterly) | -37.60% |
| Earnings Yield | -2.83% |
| Normalized Earnings Yield | -3.048 |